News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
143,529 Results
Type
Article (6080)
Company Profile (50)
Press Release (137398)
Section
Business (46257)
Career Advice (241)
Deals (8950)
Drug Delivery (18)
Drug Development (20046)
Employer Resources (22)
FDA (3479)
Job Trends (3644)
News (77229)
Policy (5633)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (464)
Accelerated approval (6)
Adcomms (4)
Allergies (41)
Alliances (7731)
ALS (42)
Alzheimer's disease (328)
Antibody-drug conjugate (ADC) (94)
Approvals (3660)
Artificial intelligence (89)
Autoimmune disease (46)
Automation (4)
Bankruptcy (44)
Best Places to Work (3047)
BIOSECURE Act (2)
Biosimilars (46)
Biotechnology (30)
Bladder cancer (53)
Brain cancer (15)
Breast cancer (186)
Cancer (1314)
Cardiovascular disease (140)
Career advice (202)
Career pathing (6)
CAR-T (59)
CDC (12)
Cell therapy (148)
Cervical cancer (13)
Clinical research (18448)
Collaboration (278)
Compensation (198)
Complete response letters (9)
COVID-19 (592)
CRISPR (22)
C-suite (104)
Cystic fibrosis (44)
Data (2099)
Depression (28)
Dermatology (21)
Diabetes (138)
Diagnostics (1387)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (47)
Drug pricing (24)
Drug shortages (6)
Duchenne muscular dystrophy (60)
Earnings (33958)
Editorial (4)
Employer resources (21)
Events (19274)
Executive appointments (101)
FDA (4456)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (6)
Frontotemporal dementia (8)
Funding (251)
Gene editing (55)
Generative AI (7)
Gene therapy (110)
GLP-1 (232)
Government (761)
Grass and pollen (1)
Guidances (296)
Healthcare (4273)
HIV (20)
Huntington's disease (14)
IgA nephropathy (26)
Immunology and inflammation (44)
Immuno-oncology (12)
Indications (53)
Infectious disease (691)
Inflammatory bowel disease (45)
Inflation Reduction Act (1)
Influenza (22)
Intellectual property (39)
Interviews (30)
IPO (5457)
IRA (4)
Job creations (748)
Job search strategy (177)
JPM (10)
Kidney cancer (7)
Labor market (28)
Layoffs (111)
Leadership (1)
Legal (948)
Liver cancer (22)
Longevity (2)
Lung cancer (164)
Lymphoma (163)
Machine learning (8)
Management (10)
Manufacturing (149)
MASH (57)
Medical device (3063)
Medtech (3077)
Mergers & acquisitions (3753)
Metabolic disorders (358)
mRNA (33)
Multiple sclerosis (51)
NASH (4)
Neurodegenerative disease (69)
Neuropsychiatric disorders (24)
Neuroscience (641)
NextGen: Class of 2026 (1171)
Non-profit (964)
Now hiring (5)
Obesity (148)
Opinion (29)
Ovarian cancer (48)
Pain (34)
Pancreatic cancer (58)
Parkinson's disease (62)
Partnered (12)
Patents (72)
Patient recruitment (117)
Peanut (25)
People (6454)
Pharmaceutical (17)
Pharmacy benefit managers (6)
Phase 1 (4893)
Phase 2 (7903)
Phase 3 (7107)
Pipeline (2707)
Policy (32)
Postmarket research (648)
Preclinical (1497)
Press Release (14)
Prostate cancer (61)
Psychedelics (7)
Radiopharmaceuticals (68)
Rare diseases (221)
Real estate (1029)
Recruiting (11)
Regulatory (4931)
Reports (18)
Research institute (425)
Resumes & cover letters (42)
Rett syndrome (6)
RNA editing (1)
RSV (57)
Schizophrenia (53)
Series A (36)
Series B (28)
Service/supplier (2)
Sickle cell disease (29)
Special edition (6)
Spinal muscular atrophy (83)
Sponsored (6)
Startups (479)
Stomach cancer (3)
Supply chain (23)
Tariffs (11)
The Weekly (2)
Vaccines (229)
Venture capital (17)
Weight loss (102)
Women's health (23)
Worklife (2)
Date
Last 7 days (162)
Last 30 days (643)
Last 365 days (7507)
2026 (1948)
2025 (7519)
2024 (8762)
2023 (9909)
2022 (12431)
2021 (13101)
2020 (12328)
2019 (10223)
2018 (7761)
2017 (6645)
2016 (5817)
2015 (7366)
2014 (5208)
2013 (3762)
2012 (3973)
2011 (4354)
2010 (3904)
Location
Africa (125)
Alabama (21)
Alaska (1)
Arizona (53)
Arkansas (1)
Asia (8564)
Australia (1075)
California (2746)
Canada (1012)
China (290)
Colorado (129)
Connecticut (104)
Delaware (116)
Europe (20424)
Florida (456)
Georgia (81)
Idaho (11)
Illinois (248)
India (18)
Indiana (142)
Iowa (3)
Japan (139)
Kansas (29)
Kentucky (7)
Louisiana (16)
Maine (52)
Maryland (340)
Massachusetts (1990)
Michigan (54)
Minnesota (134)
Mississippi (1)
Missouri (27)
Montana (2)
Nebraska (4)
Nevada (26)
New Hampshire (32)
New Jersey (1149)
New Mexico (6)
New York (816)
North Carolina (388)
North Dakota (3)
Northern California (1443)
Ohio (67)
Oklahoma (1)
Oregon (5)
Pennsylvania (610)
Rhode Island (12)
South America (202)
South Carolina (4)
Southern California (1068)
Tennessee (32)
Texas (340)
United States (10339)
Utah (78)
Vermont (1)
Virginia (35)
Washington D.C. (26)
Washington State (237)
West Virginia (1)
Wisconsin (71)
143,529 Results for "60".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
60 Degrees Pharmaceuticals Announces 2025 Annual Results
March 31, 2026
·
6 min read
Press Releases
Ovid Therapeutics Announces Pricing of $60 Million Private Placement
March 18, 2026
·
5 min read
Drug pricing
Amgen Hops on DTC Train To Offer Repatha at 60% Discount
Amgen will offer its lipid-lowering drug Repatha directly to patients for $239 per month, representing a nearly 60% reduction from the current wholesale acquisition cost of $527.70.
October 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Gilgamesh Pharma Closes Oversubscribed $60 Million Series A to Develop Next Generation Neuropsychiatric Therapies
March 24, 2026
·
3 min read
Press Releases
DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
March 25, 2026
·
4 min read
Press Releases
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
February 2, 2026
·
8 min read
Press Releases
KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility
March 13, 2026
·
3 min read
Press Releases
Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update
February 17, 2026
·
4 min read
Press Releases
Revalesio to Present Advances in Stroke Treatment with RNS60 at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting
March 5, 2026
·
5 min read
Press Releases
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
March 11, 2026
·
10 min read
1 of 14,353
Next
